HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder
Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder image
Selinexor Treatment Information Chapter
event Feb 15, 2022 / 07:00PM - 08:00PM EST

Event Description

What kind of success have we seen when using selinexor (XPOVIO) in different combinations? What is clinical trial data telling and us and what could the future of selinexor look like? Myeloma specialist Dr. Jeffrey Zonder will join us to discuss.

Schedule & Agenda

Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Jeffrey Zonder.
Dr. Jeffrey Zonder
Dr. Jeffrey Zonder talks about what kind of success we have seen when using selinexor (XPOVIO) in different combinations, what clinical trial data is telling us and what could the future of selinexor look like. 
Questions and Answers
Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Jeffrey Zonder, M.D.
Jeffrey Zonder, M.D.

Professor in the Departments of Oncology at the Barbara Ann Karmanos Cancer Institute (KCI) and Wayne State University School of Medicine. He is the leader of the KCI Multiple Myeloma and Amyloidosis Multidisciplinary Team and co-leader of Molecular Therapeutic Program. He is e member of the Steering Committee at the Multiple Myeloma Research Consortium, a medical advisor for the Amyloidosis Support Group Networks, and a member of the International Myeloma Working Group, the International Myeloma Society and the International Amyloidosis Society. He is a member of the Southwest Oncology Group’s (SWOG) Barlogie-Salmon Myeloma Committee. Dr. Zonder has authored or co-authored numerous original research papers, review articles, book chapters, and research abstracts on myeloma and amyloidosis. He completed a fellowship in hematology-oncology at Wayne State University and his medical residency at the University of Rochester, New York. He received his medical degree from Wayne State University School of Medicine.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us


+1 800 709 1113


Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube